Results 31 to 40 of about 567,487 (125)

Anesthesia strategy for factor X deficiency coagulopathy: case report

Brazilian Journal of Anesthesiology, 2022
Factor X deficiency ranks among the rarest coagulopathies and has a variable presentation spectrum. We intend to present a proposal for anesthesia protocol for individuals with the coagulopathy.
Carla Isabel Ferreira, Fábio Costa, Ana Rita Arantes, Graça Horta, Elsa Soares, Filipa Félix   +5 more
doaj  

Gastrointestinal Bleeding From Acquired Factor X Deficiency due to Light Chain Amyloidosis

Gastro Hep Advances
Kyle S. Liu, Xiuli Liu, Elizabeth Blaney
doaj   +2 more sources

Efficacy, safety and pharmacokinetics of a new high‐purity factor X concentrate in women and girls with hereditary factor X deficiency

Journal of Thrombosis and Haemostasis, 2018
Essentials Plasma‐derived factor X concentrate (pdFX) is used to treat hereditary factor X deficiency. pdFX pharmacokinetics, safety and efficacy were assessed in factor X‐deficient women/girls.
R. Kulkarni, Andra H. James, M. Norton, A. D. Shapiro   +3 more
semanticscholar   +1 more source

Successful Treatment of Factor X Deficiency in a Patient with Lymphoplasmacytic Lymphoma with Bendamustine Plus Rituximab Regimen: A Case Report and Literature Review

Journal of Blood Medicine, 2021
Tarinee Rungjirajittranon, Yingyong Chinthammitr, Chattree Hantaweepant Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandCorrespondence: Chattree HantaweepantClinical Lecturer of ...
Rungjirajittranon T, Chinthammitr Y, Hantaweepant C   +2 more
doaj  

Autosomal recessive inherited bleeding disorders in Pakistan: a cross-sectional study from selected regions

Orphanet Journal of Rare Diseases, 2017
Background Autosomal recessive bleeding disorders (ARBDs) include deficiencies of clotting factors I, II, V, VII, X, XI, XIII, vitamin K dependent clotting factors, combined factor V & VIII, Von Willebrand Disease (vWD) type 3, Glanzmann’s thrombasthenia
Arshi Naz, Muhammad Younus Jamal, Samina Amanat, Ikram Din ujjan, Akber Najmuddin, Humayun Patel, Fazle Raziq, Nisar Ahmed, Ayisha Imran, Tahir Sultan Shamsi   +9 more
doaj   +1 more source

Acquired factor X deficiency in a patient with multiple myeloma: a rare case highlighting the significance of comprehensive evaluation and the need for antimyeloma therapy for bleeding diathesis

BMJ Case Reports, 2019
Factor X deficiency is a rare bleeding disorder that can be associated with life-threatening bleeding events. Factor X deficiency can either be inherited or acquired.
S. Reynolds, Dhaval P. Maghavani, Hamza Hashmi   +2 more
semanticscholar   +1 more source

Acquired Factor X Deficiency without Amyloidosis Presenting with Massive Hematuria: A Case Report and Review of the Literature

Hematology Reports, 2023
Acquired factor X deficiency is a rare diagnosis, especially without the association of other co-existing conditions such as amyloidosis. The authors report the case of a 34-year-old male with severe frank hematuria found to have markedly prolonged ...
Sasmith R. Menakuru, Vijaypal S. Dhillon, Ahmed Salih, Amir F. Beirat   +3 more
doaj   +1 more source

Parapharyngeal hematoma following transesophageal echo in a patient with hemophilia A

Clinical Case Reports, 2023
Key Clinical Message Hemophilia A is an X‐linked disorder caused by deficiency of Factor VIII. Postoperative patients with mild hemophilia A, or those requiring intensive factor replacement, should be proactively screened for factor inhibitor development.
Dominic McKenna, Teodora Pampu, Marian Korda, Gary Benson   +3 more
doaj   +1 more source

Severe congenital factor X deficiency – An unusual cause of intracranial hemorrhage

Journal of Pediatric Critical Care, 2018
Factor X deficiency is one of the rare inherited coagulation disorders. Symptoms vary from mild to severe with the commonest being epistaxis, gum bleeds and menorrhagia.
T P Vigneshwaran, A R Mullai Baalaaji, S Ashok Kumar, D Ashwath, Thirugnanam Rajasekar   +4 more
doaj   +1 more source

Prophylactic treatment of bleeding episodes in children <12 years with moderate to severe hereditary factor X deficiency (FXD): Efficacy and safety of a high‐purity plasma‐derived factor X (pdFX) concentrate

Haemophilia, 2018
Hereditary factor X (FX) deficiency (FXD) affects 1:500 000‐1:1 000 000 people worldwide. A novel, high‐purity plasma‐derived FX concentrate (pdFX) is available in the United States and European Union as replacement therapy for FXD, but data are scarce ...
R. Liesner, C. Akanezi, Miranda Norton, J. Payne   +3 more
semanticscholar   +1 more source